The volume of AstraZeneca COVID-19 vaccine manufactured at SK Bioscience Andong plant for export cleared for lot release has exceeded the volume for domestic supply.

The AstraZeneca Korea COVID-19 Vaccine manufactured by SK Bioscience was authorized on Feb. 10, which the National Lot Release cleared 1.57 million doses of it on Feb. 17. Since then, South Korea’s Ministry of Food and Drug Safety (MFDS) has been consistently approving the lot release for the export use.

MFDS official reported on Mar. 10, 18 serialized batches were approved for export as of Mar. 9. As each serial number is given on 300,000 doses, basically about 5.4 million doses for export were cleared of lot release.

Lee, Tak-Sun(hooggasi2@dailypharm.com)